TrialAnnals of clinical and translational neurology2019

TMS as a pharmacodynamic indicator of cortical activity of a novel anti-epileptic drug, XEN1101.

Isabella Premoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.